The research team of the University of Hawai'i's School of Life Sciences, led by Professor Tung Hoang, have received a $3-million contract from the Defense Threat Reduction Agency in the U.S. Department of Defense to create a vaccine against melioidosis, or Whitmore's disease.

Professor Tung Hoang (L) works with a member of his research team at the University of Hawai’i in Mānoa.

The awarding of the contract was announced on the university’s website.

Melioidosis is an infectious disease that spreads to humans through cuts in their skin, consuming contaminated water or inhaling particles containing the bacterium Burkholderia pseudomallei.

Its symptoms include fever, pneumonia, abscesses and inflammation of the brain and joints. The disease is frequently misdiagnosed as tuberculosis. It is known to cause various types of infection, including pulmonary, localized, bloodstream and disseminated infections, all of which can be fatal. The disease’s mortality rate is 40 percent.

UH researchers have studied Burkholderia pseudomallei for more than 10 years.

They discovered two specific surface proteins that allow the bacterium to attach to human cells for infection. Without these proteins, the bacterium is much less infectious.

These findings were released in a March 2021 study published in Nature Communications.

He said his team has used the two proteins to create a vaccine and their study showed 100 percent effectiveness in mice. Unvaccinated mice died within five days, while 100 percent of vaccinated mice survived for at least one month, which was the duration of the study. Based on this finding, they submitted an application to the Defense Threat Reduction Agency.

Whitmore's disease was first diagnosed in Vietnam in 1925, though sufficient knowledge of the illness is still lacking.

Around 10,000 cases are reported worldwide each year, mostly during the rainy season, around half of which prove fatal. There has been no vaccine against the disease so far.

Tung Hoang is a full professor at the Department of Microbiology at the UH. He received his Bachelor of Science Degree in Biochemistry from the University of Calgary, Canada, in 1994.

He joined the faculty in the Department of Microbiology at UHM, as an Assistant Professor in 2002 and later became a full professor.

Vaccine passport program readied for foreigners to visit Phu Quoc Island

The tourism ministry is urgently working on a plan for welcoming international tourists with the so-called Covid-19 vaccine passports to Phu Quoc Island in Kien Giang Province.

More donors contribute to national Covid-19 vaccine fund

The national Covid-19 vaccine fund received over VND 6.6 billion from 17 sponsors at a ceremony on June 24.

PM: Vietnam must be able to produce Covid-19 vaccines no later than June 2022

Prime Minister Pham Minh Chinh has requested accelerating the transfer of vaccine production technology and the testing and production of home-grown vaccine for Covid-19, so that Vietnam will be able to produce Covid-19 vaccines no later than June 2022.

Vietnam among beneficiaries of US vaccine donation

The U.S. has announced the destinations of 55 million doses of Covid-19 vaccines, and Vietnam is among them.

Final phase trials: 924 volunteers get made-in-Vietnam vaccine jabs

924 volunteers had participated in the third phase of human trials for the homegrown Covid-19 vaccine Nanocovax.

Source: VnExpress